No abstract available
Keywords:
CD34+; myelofibrosis; prognosis; ruxolitinib.
Publication types
-
Letter
-
Research Support, Non-U.S. Gov't
-
Comment
MeSH terms
-
Humans
-
Nitriles
-
Primary Myelofibrosis*
-
Prognosis
-
Pyrimidines
Substances
-
ruxolitinib
-
Nitriles
-
Pyrimidines